Risk Factors for Severe Coronavirus Disease 2019 Among Human Immunodeficiency Virus-Infected and -Uninfected Individuals in South Africa, April 2020–March 2022: Data From Sentinel Surveillance

Author:

Walaza Sibongile12,Tempia Stefano1234,von Gottberg Anne15,Wolter Nicole15,Bhiman Jinal N15,Buys Amelia1,Amoako Daniel1,Moosa Fahima15,du Plessis Mignon15,Moyes Jocelyn12,McMorrow Meredith L64,Dawood Halima78,Variava Ebrahim910,Reubenson Gary11,Nel Jeremy10,Zar Heather J12,Makhasi Mvuyo1,Meiring Susan213,Quan Vanessa13,Cohen Cheryl12

Affiliation:

1. Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service , Johannesburg , South Africa

2. School of Public Health, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg , South Africa

3. MassGenics , Atlanta, Georgia , USA

4. Influenza Program, Centers for Disease Control and Prevention , Pretoria , South Africa

5. School of Pathology, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg , South Africa

6. Influenza Program, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta , Georgia , USA

7. Department of Medicine, Greys Hospital , Pietermaritzburg , South Africa

8. Caprisa, University of KwaZulu - Natal , Pietermaritzburg , South Africa

9. Department of Medicine, Klerksdorp-Tshepong Hospital Complex , Klerksdorp , South Africa

10. Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg , South Africa

11. Department of Paediatrics and Child Health, Faculty of Health Sciences, University of the Witwatersrand, Rahima Moosa Mother and Child Hospital , Johannesburg , South Africa

12. Department of Paediatrics, Red Cross War Memorial Hospital, and South African-Medical Research Council on Child and Adolescent Health, University of Cape Town , South Africa

13. Divison of Public Health Surveillance and Response, National Institute for Communicable Diseases of the National Health Laboratory Service , Johannesburg , South Africa

Abstract

Abstract Background Data on risk factors for coronavirus disease 2019 (COVID-19)-associated hospitalization and mortality in high human immunodeficiency virus (HIV) prevalence settings are limited. Methods Using existing syndromic surveillance programs for influenza-like-illness and severe respiratory illness at sentinel sites in South Africa, we identified factors associated with COVID-19 hospitalization and mortality. Results From April 2020 through March 2022, severe acute respiratory syndrome coronavirus 2 was detected in 24.0% (660 of 2746) of outpatient and 32.5% (2282 of 7025) of inpatient cases. Factors associated with COVID-19-associated hospitalization included the following: older age (25–44 [adjusted odds ratio {aOR}= 1.8, 95% confidence interval (CI) = 1.1–2.9], 45–64 [aOR = 6.8, 95% CI = 4.2–11.0] and ≥65 years [aOR = 26.6, 95% CI = 14.4–49.1] vs 15–24 years); black race (aOR, 3.3; 95% CI, 2.2–5.0); obesity (aOR, 2.3; 95% CI, 1.4–3.9); asthma (aOR, 3.5; 95% CI, 1.4–8.9); diabetes mellitus (aOR, 5.3; 95% CI, 3.1–9.3); HIV with CD4 ≥200/mm3 (aOR, 1.5; 95% CI, 1.1–2.2) and CD4 <200/mm3 (aOR, 10.5; 95% CI, 5.1–21.6) or tuberculosis (aOR, 12.8; 95% CI, 2.8–58.5). Infection with Beta (aOR, 0.5; 95% CI, .3–.7) vs Delta variant and being fully vaccinated (aOR, 0.1; 95% CI, .1–.3) were less associated with COVID-19 hospitalization. In-hospital mortality was increased in older age (45–64 years [aOR, 2.2; 95% CI, 1.6–3.2] and ≥65 years [aOR, 4.0; 95% CI, 2.8–5.8] vs 25–44 years) and male sex (aOR, 1.3; 95% CI, 1.0–1.6) and was lower in Omicron-infected (aOR, 0.3; 95% CI, .2–.6) vs Delta-infected individuals. Conclusions Active syndromic surveillance encompassing clinical, laboratory, and genomic data identified setting-specific risk factors associated with COVID-19 severity that will inform prioritization of COVID-19 vaccine distribution. Elderly people with tuberculosis or people with HIV, especially severely immunosuppressed, should be prioritized for vaccination.

Funder

Wellcome Trust

Foreign, Commonwealth and Development Office

US Centers for Disease Control and Prevention

CDC

African Field Epidemiology Network

South African Medical Research Council

African Society of Laboratory Medicine

Africa Centers for Disease Control and Prevention

Bill & Melinda Gates Foundation

National Institute for Communicable Diseases

National Health Laboratory Service, South Africa

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3